Manufacturer of Controlled Substances; Notice of Application, 11149-11150 [E8-3875]

Download as PDF 11149 Federal Register / Vol. 73, No. 41 / Friday, February 29, 2008 / Notices rwilkins on PROD1PC63 with NOTICES of such a substance, provide manufacturers holding registrations for the bulk manufacture of the substance an opportunity for a hearing. Therefore, in accordance with Title 21 Code of Federal Regulations (CFR), 1301.34(a), this is notice that on January 28, 2008, Meridian Medical Technologies, 2555 Hermelin Drive, St. Louis, Missouri 63144, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as an importer of Morphine (9300), a basic class of controlled substance listed in schedule II. The company plans to import products for research experimentation or clinical use and analytical testing. Any bulk manufacturer who is presently, or is applying to be, registered with DEA to manufacture such basic class of controlled substance may file comments or objections to the issuance of the proposed registration and may, at the same time, file a written request for a hearing on such application pursuant to 21 CFR 1301.43 and in such form as prescribed by 21 CFR 1316.47. Any such written comments or objections being sent via regular mail should be addressed, in quintuplicate, to the Drug Enforcement Administration, Office of Diversion Control, Federal Register Representative (ODL), Washington, DC 20537, or any being sent via express mail should be sent to Drug Enforcement Administration, Office of Diversion Control, Federal Register Representative (ODL), 8701 Morrissette Drive, Springfield, Virginia 22152; and must be filed no later than March 31, 2008. This procedure is to be conducted simultaneously with and independent of the procedures described in 21 CFR 1301.34(b), (c), (d), (e) and (f). As noted in a previous notice published in the Federal Register on September 23, 1975, (40 FR 43745–46), all applicants for registration to import a basic class of any controlled substance listed in schedule I or II are, and will continue to be, required to demonstrate to the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration, that the requirements for such registration pursuant to 21 U.S.C. 958(a), 21 U.S.C. 823(a), and 21 CFR 1301.34(b), (c), (d), (e) and (f) are satisfied. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. E8–3858 Filed 2–28–08; 8:45 am] BILLING CODE 4410–09–P VerDate Aug<31>2005 19:22 Feb 28, 2008 Jkt 214001 DEPARTMENT OF JUSTICE Drug Enforcement Administration Importer of Controlled Substances; Notice of Application Pursuant to 21 U.S.C. 958(i), the Attorney General shall, prior to issuing a registration under this section to a bulk manufacturer of a controlled substance in schedule I or II, and prior to issuing a registration under 21 U.S.C. 952(a)(2) authorizing the importation of such a substance, provide manufacturers holding registrations for the bulk manufacture of the substance an opportunity for a hearing. Therefore, in accordance with Title 21 Code of Federal Regulations (CFR), 1301.34(a), this is notice that on January 14, 2008, Supernus Pharmaceuticals, 1550 East Gude Drive, Rockville, Maryland 20850, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as an importer of the basic classes of controlled substances listed in schedule II: Drug Schedule Oxycodone (9143) ........................ Morphine (9300) ........................... II II The company plans to import controlled substances for clinical trials and analytical testing. Any bulk manufacturer who is presently, or is applying to be, registered with DEA to manufacture such basic classes of controlled substances may file comments or objections to the issuance of the proposed registration and may, at the same time, file a written request for a hearing on such application pursuant to 21 CFR 1301.43 and in such form as prescribed by 21 CFR 1316.47. Any such comments or objections being sent via regular mail should be addressed, in quintuplicate, to the Drug Enforcement Administration, Office of Diversion Control, Federal Register Representative (ODL), Washington, DC 20537, or any being sent via express mail should be sent to Drug Enforcement Administration, Office of Diversion Control, Federal Register Representative (ODL), 8701 Morrissette Drive, Springfield, VA. 22152; and must be filed no later than March 31, 2008. This procedure is to be conducted simultaneously with, and independent of, the procedures described in 21 CFR 1301.34(b), (c), (d), (e) and (f). As noted in a previous notice published in the Federal Register on September 23, 1975, (40 FR 43745–46), all applicants for registration to import a basic class of PO 00000 Frm 00062 Fmt 4703 Sfmt 4703 any controlled substances in schedule I or II are, and will continue to be, required to demonstrate to the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration, that the requirements for such registration pursuant to 21 U.S.C. 958(a); 21 U.S.C. 823(a); and 21 CFR 1301.34(b), (c), (d), (e), and (f) are satisfied. Dated: February 20, 2008. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. E8–3874 Filed 2–28–08; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Drug Enforcement Administration Manufacturer of Controlled Substances; Notice of Application Pursuant to § 1301.33(a) of Title 21 of the Code of Federal Regulations (CFR), this is notice that on January 23, 2008, Stepan Company, Natural Products Dept., 100 W. Hunter Avenue, Maywood, New Jersey 07607, made application by renewal to the Drug Enforcement Administration (DEA) as a bulk manufacturer of the basic classes of controlled substances listed in schedule II: Drug Coca Leaves (9040) ..................... Cocaine (9041) ............................. Benzoylecgonine (9180) ............... Schedule II II II The company plans to manufacture the listed controlled substances in bulk for distribution to its customers. Any other such applicant and any person who is presently registered with DEA to manufacture such substances may file comments or objections to the issuance of the proposed registration pursuant to 21 CFR 1301.33(a). Any such written comments or objections being sent via regular mail should be addressed, in quintuplicate, to the Drug Enforcement Administration, Office of Diversion Control, Federal Register Representative (ODL), Washington, DC 20537, or any being sent via express mail should be sent to Drug Enforcement Administration, Office of Diversion Control, Federal Register Representative (ODL), 8701 Morrissette Drive, Springfield, Virginia 22152, and must be filed no later than April 29, 2008. E:\FR\FM\29FEN1.SGM 29FEN1 11150 Federal Register / Vol. 73, No. 41 / Friday, February 29, 2008 / Notices Dated: February 20, 2008. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. E8–3875 Filed 2–28–08; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Federal Bureau Of Prisons Notice of the Availability of the Draft Environmental Assessment for the Proposed Federal Correctional Institution—Hazelton, WV U.S. Department of Justice, Federal Bureau of Prisons. ACTION: Public Comment on Draft Environmental Assessment. AGENCY: The U.S. Department of Justice, Federal Bureau of Prisons (BOP) announces the availability of the Draft Environmental Assessment (EA) for the proposed development of a Federal Correctional Institution (FCI) to be located in Hazelton, Preston County, West Virginia. The BOP is seeking to expand the facilities that currently exist at BOP’s USP Hazelton facility due to a growing population of federal inmates and an increased demand in the Mid-Atlantic Region for facilities to house the growing inmate population. SUMMARY: rwilkins on PROD1PC63 with NOTICES Background Information Pursuant to Section 102(2)(c) of the National Environmental Policy Act of 1969 and the Council of Environmental Quality Regulations (40 CFR parts 1500– 1508), BOP has prepared a Draft Environmental Assessment (EA) for a medium-security FCI to house approximately 1,200 adult male inmates in Hazelton, West Virginia. USP Hazelton occupies 915 acres and is currently comprised of a high-security penitentiary housing approximately 1,608 male inmates, a Secured Female Facility (SFF) housing approximately 623 female inmates and a Federal Prison Camp (FPC) housing approximately 124 low-security inmates. Environmental studies were conducted before the construction of the USP Hazelton and the FPC in 1999, and the SFF in 2000. It is the intent of the BOP to construct the FCI on a portion of the existing 915 acres currently owned by BOP. Project Information The proposed action in Hazelton, West Virginia, is part of the BOP’s comprehensive expansion effort to accommodate an increasing federal inmate population and reduce system- VerDate Aug<31>2005 19:22 Feb 28, 2008 Jkt 214001 wide inmate crowding. The proposed action would consist of construction and operation of a medium-security FCI at the existing USP Hazelton facility. The principal function of the correctional facility would be to provide a safe, secure and humane environment for the care and custody of federal inmates, primarily from the MidAtlantic region of the country. Upon activation, the facility would have a staff of approximately 250 full-time employees who would provide 24-hour supervision. Development of the proposed facility will occur on 250 acres of the 915 acres comprising the existing USP Hazelton facilities. An Environmental Impact Statement (EIS) was prepared for the original development of the 915-acre site in 1999 and additional environmental studies were prepared for further development of the site in 2000. The current EA is being undertaken to evaluate current environmental, cultural and socioeconomic resources and potential impacts of the proposed FCI. The previous NEPA documents included the area currently being evaluated in this EA. Notice of Availability of the Draft Environmental Assessment The BOP evaluated alternatives as part of the Draft EA including the No Action Alternative and development of three alternative placements of the facility on the proposed site. Each of the alternatives located on the 250-acre site in Hazelton, West Virginia, was evaluated in the Draft EA, with the development of Option C being identified by the Draft EA as the Preferred Alternative. The Draft EA will be the subject of a 30-day review period which begins February 29, 2008 and ends March 30, 2008. Comments concerning the Draft EA and the proposed action must be received during this time to be assured of consideration. All written comments received during this review period will be taken into consideration by the BOP. Copies of the Draft EA are available for public viewing at: Preston County Courthouse, 101 West Main Street, Room 101, Kingwood, WV 26537. Kingwood Public Library, 205 West Main Street, Kingwood, WV 26537. Terra Alta Public Library, 701B East State Avenue, Terra Alta, WV 26764. The Draft EA and other information regarding this project are available upon request. To request a copy of the Draft EA, please contact: Pamela J. Chandler, Chief, or Issac J. Gaston, Site Selection Specialist, Site Selection and Environmental Review PO 00000 Frm 00063 Fmt 4703 Sfmt 4703 Branch, Federal Bureau of Prisons, 320 First Street, NW., Washington, DC 20534 Tel: 202–514–6470, Fax: 202– 616–6024 / E-mail: pchandler@bop.gov or igaston@bop.gov. FOR FURTHER INFORMATION CONTACT: Pamela J. Chandler, or Issac J. Gaston, Federal Bureau of Prisons. Dated: February 22, 2008. Issac J. Gaston, Site Specialist, Site Selection and Environmental Review Branch. [FR Doc. E8–3680 Filed 2–28–08; 8:45 am] BILLING CODE 4410–05–P DEPARTMENT OF LABOR Employment and Training Administration [TA–W–62,276] F.L. Smithe Machine Company Duncansville, PA; Notice of Affirmative Determination Regarding Application for Reconsideration By applications dated January 16, 2008 and January 19, 2008, the International Association of Machinists and Aerospace Workers and a company official, respectively, requested administrative reconsideration of the Department of Labor’s Notice of Negative Determination Regarding Eligibility to Apply for Worker Adjustment Assistance, applicable to workers and former workers of the subject firm. The denial notice was signed on December 28, 2007 and published in the Federal Register on January 16, 2008 (73 FR 2944). The initial investigation resulted in a negative determination based on the finding that imports of envelope making machines, printing presses and related parts did not contribute importantly to worker separations at the subject firms and no shift of production to a foreign source occurred. In the request for reconsideration, both petitioners indicated that not enough information was supplied pertaining to printing press machines manufactured at the subject plant. The Department has carefully reviewed the requests for reconsideration and the existing record and determined that the Department will conduct further investigation to determine if the workers meet the eligibility requirements of the Trade Act of 1974. Conclusion After careful review of the applications, I conclude that the claim is of sufficient weight to justify E:\FR\FM\29FEN1.SGM 29FEN1

Agencies

[Federal Register Volume 73, Number 41 (Friday, February 29, 2008)]
[Notices]
[Pages 11149-11150]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-3875]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Application

    Pursuant to Sec.  1301.33(a) of Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on January 23, 2008, Stepan 
Company, Natural Products Dept., 100 W. Hunter Avenue, Maywood, New 
Jersey 07607, made application by renewal to the Drug Enforcement 
Administration (DEA) as a bulk manufacturer of the basic classes of 
controlled substances listed in schedule II:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Coca Leaves (9040).........................  II
Cocaine (9041).............................  II
Benzoylecgonine (9180).....................  II
------------------------------------------------------------------------

    The company plans to manufacture the listed controlled substances 
in bulk for distribution to its customers.
    Any other such applicant and any person who is presently registered 
with DEA to manufacture such substances may file comments or objections 
to the issuance of the proposed registration pursuant to 21 CFR 
1301.33(a).
    Any such written comments or objections being sent via regular mail 
should be addressed, in quintuplicate, to the Drug Enforcement 
Administration, Office of Diversion Control, Federal Register 
Representative (ODL), Washington, DC 20537, or any being sent via 
express mail should be sent to Drug Enforcement Administration, Office 
of Diversion Control, Federal Register Representative (ODL), 8701 
Morrissette Drive, Springfield, Virginia 22152, and must be filed no 
later than April 29, 2008.


[[Page 11150]]


    Dated: February 20, 2008.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
 [FR Doc. E8-3875 Filed 2-28-08; 8:45 am]
BILLING CODE 4410-09-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.